UBS AM’s Opko Health OPK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $861K | Sell |
574,107
-100,741
| -15% | -$128K | ﹤0.01% | 2389 |
|
|
2026
Q1 | $769K | Buy |
674,848
+1,283
| +0.2% | +$1.58K | ﹤0.01% | 2430 |
|
|
2025
Q4 | $849K | Hold |
673,565
| – | – | ﹤0.01% | 2193 |
|
|
2025
Q3 | $1.04M | Sell |
673,565
-453,911
| -40% | -$623K | ﹤0.01% | 1991 |
|
|
2025
Q2 | $1.49M | Buy |
1,127,476
+345,842
| +44% | +$473K | ﹤0.01% | 2272 |
|
|
2025
Q1 | $1.3M | Buy |
781,634
+28,254
| +4% | +$46.5K | ﹤0.01% | 2199 |
|
|
2024
Q4 | $1.11M | Buy |
753,380
+148,322
| +25% | +$227K | ﹤0.01% | 2321 |
|
|
2024
Q3 | $902K | Sell |
605,058
-149,104
| -20% | -$221K | ﹤0.01% | 2451 |
|
|
2024
Q2 | $943K | Buy |
754,162
+352,973
| +88% | +$458K | ﹤0.01% | 2402 |
|
|
2024
Q1 | $481K | Hold |
401,189
| – | – | ﹤0.01% | 2300 |
|
|
2023
Q4 | $606K | Hold |
401,189
| – | – | ﹤0.01% | 2258 |
|
|
2023
Q3 | $642K | Sell |
401,189
-39,093
| -9% | -$71.2K | ﹤0.01% | 2181 |
|
|
2023
Q2 | $643K | Hold |
440,282
| – | – | ﹤0.01% | 2224 |
|
|
2023
Q1 | $643K | Buy |
440,282
+106,211
| +32% | +$137K | ﹤0.01% | 2224 |
|
|
2022
Q4 | $418K | Hold |
334,071
| – | – | ﹤0.01% | 2246 |
|
|
2022
Q3 | $631K | Sell |
334,071
-116,125
| -26% | -$275K | ﹤0.01% | 2234 |
|
|
2022
Q2 | $1.14M | Sell |
450,196
-14,389
| -3% | -$42K | ﹤0.01% | 1885 |
|
|
2022
Q1 | $1.6M | Buy |
464,585
+4,366
| +0.9% | +$15.4K | ﹤0.01% | 1909 |
|
|
2021
Q4 | $2.21M | Buy |
460,219
+29,127
| +7% | +$118K | ﹤0.01% | 1820 |
|
|
2021
Q3 | $1.57M | Buy |
431,092
+4,577
| +1% | +$17K | ﹤0.01% | 1943 |
|
|
2021
Q2 | $1.73M | Buy |
426,515
+12,456
| +3% | +$48.8K | ﹤0.01% | 1920 |
|
|
2021
Q1 | $1.78M | Sell |
414,059
-112,264
| -21% | -$536K | ﹤0.01% | 1795 |
|
|
2020
Q4 | $2.08M | Buy |
526,323
+92,528
| +21% | +$386K | ﹤0.01% | 1667 |
|
|
2020
Q3 | $1.6M | Buy |
433,795
+49,921
| +13% | +$211K | ﹤0.01% | 1640 |
|
|
2020
Q2 | $1.31M | Buy |
383,874
+129,527
| +51% | +$290K | ﹤0.01% | 1689 |
|
|
2020
Q1 | $341K | Buy |
254,347
+16,565
| +7% | +$26K | ﹤0.01% | 2120 |
|
|
2019
Q4 | $350K | Sell |
237,782
-15,917
| -6% | -$26.6K | ﹤0.01% | 2337 |
|
|
2019
Q3 | $530K | Buy |
253,699
+38,708
| +18% | +$79.1K | ﹤0.01% | 2262 |
|
|
2019
Q2 | $525K | Sell |
214,991
-60,655
| -22% | -$132K | ﹤0.01% | 2191 |
|
|
2019
Q1 | $719K | Sell |
275,646
-24,943
| -8% | -$75.5K | ﹤0.01% | 1952 |
|
|
2018
Q4 | $905K | Hold |
300,589
| – | – | ﹤0.01% | 1794 |
|
|
2018
Q3 | $1.04M | Hold |
300,589
| – | – | ﹤0.01% | 1799 |
|
|
2018
Q2 | $1.41M | Sell |
300,589
-16,845
| -5% | -$63.9K | ﹤0.01% | 1665 |
|
|
2018
Q1 | $1.01M | Buy |
317,434
+39,900
| +14% | +$161K | ﹤0.01% | 1779 |
|
|
2017
Q4 | $1.36M | Buy |
277,534
+40,626
| +17% | +$236K | ﹤0.01% | 1607 |
|
|
2017
Q3 | $1.63M | Buy |
236,908
+12,240
| +5% | +$77.2K | ﹤0.01% | 1488 |
|
|
2017
Q2 | $1.48M | Buy |
224,668
+17,541
| +8% | +$123K | ﹤0.01% | 1486 |
|
|
2017
Q1 | $1.66M | Buy |
207,127
+36,153
| +21% | +$304K | ﹤0.01% | 1423 |
|
|
2016
Q4 | $1.59M | Sell |
170,974
-78,903
| -32% | -$816K | ﹤0.01% | 1381 |
|
|
2016
Q3 | $2.65M | Buy |
249,877
+1,400
| +0.6% | +$13.9K | ﹤0.01% | 1269 |
|
|
2016
Q2 | $2.32M | Buy |
248,477
+13,699
| +6% | +$139K | ﹤0.01% | 1311 |
|
|
2016
Q1 | $2.44M | Sell |
234,778
-35,904
| -13% | -$328K | ﹤0.01% | 1292 |
|
|
2015
Q4 | $2.72M | Buy |
270,682
+4,300
| +2% | +$43.1K | ﹤0.01% | 1300 |
|
|
2015
Q3 | $2.24M | Buy |
266,382
+94,838
| +55% | +$1.26M | ﹤0.01% | 1371 |
|
|
2015
Q2 | $2.76M | Buy |
171,544
+49,149
| +40% | +$764K | ﹤0.01% | 1258 |
|
|
2015
Q1 | $1.73M | Buy |
122,395
+18,900
| +18% | +$246K | ﹤0.01% | 1418 |
|
|
2014
Q4 | $1.03M | Buy |
103,495
+4,900
| +5% | +$41.9K | ﹤0.01% | 1580 |
|
|
2014
Q3 | $839K | Buy |
98,595
+1,400
| +1% | +$12.3K | ﹤0.01% | 1622 |
|
|
2014
Q2 | $859K | Hold |
97,195
| – | – | ﹤0.01% | 1629 |
|
|
2014
Q1 | $906K | Hold |
97,195
| – | – | ﹤0.01% | 1607 |
|
|
2013
Q4 | $820K | Buy |
97,195
+3,800
| +4% | +$38.4K | ﹤0.01% | 1592 |
|
|
2013
Q3 | $823K | Buy |
93,395
+39,000
| +72% | +$313K | ﹤0.01% | 1576 |
|
|
2013
Q2 | $386K | Buy |
+54,395
| New | +$376K | ﹤0.01% | 1830 |
|
Other funds holding OPK
RCMNY
WCM
UBS AM's OPK Position: Q2 2026 in Review
UBS AM reduced its Opko Health (OPK) stake by 15% in Q2 2026, selling an estimated $128K and leaving 574,107 shares worth $861K. The position accounts for ﹤0.01% of the portfolio, ranked #2389.
UBS AM first reported a position in OPK in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.76M in Q2 2015. 223 funds tracked by Wall St. Rank hold OPK as of Q2 2026.
- UBS AM held 574,107 shares of Opko Health worth $861K as of Q2 2026.
- UBS AM sold 100,741 Opko Health shares in Q2 2026, an estimated $128K.
- Opko Health made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2389 holding.
- UBS AM first reported a position in Opko Health in Q2 2013 and has held it in 53 quarters since.
- UBS AM's Opko Health position peaked at $2.76M in Q2 2015.
- 223 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.